IDH1 and cancer: One recent example is the discovery of AG−120 [64] (ivosidenib) (80) (Figure 14), a highly specific, allosteric, reversible inhibitor of the isocitrate dehydrogenase−1 (IDH1) mutant enzyme (a mutation present in several types of cancer).